BRÖSTCANCER - Karolinska Sjukhuset

2009
Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor
survival despite intensive treatment. PloS One. 2009 Nov 11;4(11):e7695.
Hackshaw A, Baum M, Fornander T, Nordenskjöld B, Nicolucci A, Monson K, Forsyth s, Reczko K, Johannson
U, Valnetini M, Sainsbury R. Long-term effectiveness of adjuvant goserelin in premenopausal women with
early breast cancer. J Natl Cancer Inst 2009;101:341-9.
Jansson A, Delander L, Gunnarsson C, Fornander T, Skoog L, Nordenskjöld B, Stål O. Ratio of 17HSD2 protein
expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients. Clin
Cancer Res. 2009 May 15;15(10):3610-6.
Koscielny S, Arriagada R, Adolfsson J, Fornander T, Bergh J. Impact of tumour size on axillary involvement
and distant dissemination in breast cancer. Br J Cancer 2009 Sep 15;101(6):902-7.
Lambe M, Wigertz A, Holmqvist M, Adolfsson J, Bardage C, Fornander T, Karlsson P, Odlind V, Persson I,
Ahlgren J, Bergkvist L. Reductions in use of hormone replacement therapy: effects on Swedish breast
cancer incidence trends only seen after several years. Breast Cancer Res Treat. 2009 Nov 6.
Linderholm BK, Hellborg H, Johansson U, Elmberger G, Skoog L, Lehtiö J, Lewensohn R. Significant higher
levels of vacular endothelial growth factor (VEGF) and shorter survival times for patients with primary
operable triple-negative breast cancer. Ann Oncol E-publ June 23, 2009.
Linderholm B, Bergqvist J, Hellborg H, Johansson U, Linderholm M , von Schoultz E, Elmberger G, Skoog L,
Bergh J. Shorter survival times following endocrine therapy in oestorgen- and progesterone-receptor
positive breast cancer overexpressin HER2 and/or with an increased expression of endothelial growth
factor. Med Oncol. 2009 Dec;26(4):480-90.
Tan BK, Lim GH, Czene K, Hall P, Chia KS. Do Asian breast cancer patients have poorer survival than their
western counterparts? A comparison between Singapore and Stockholm. Breast Cancer Res.
2009;11(1):R4.
Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in
chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res
Treat. 2009 Oct;117(3):561-7.
Waltersson MA, Askmalm MS, Nordenskjöld B, Fornander T, Skoog L, Stål O. Altered expression of cyclin E
and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer. Int J Oncol. 2009
Feb;34(2):441-8.
2010
Dalberg K, Krawiec K, Sandelin K. Eleven-Year Follow-Up of a Randomized Study of Pectotal Fascia
Preservation After Mastectomy for Early Breast Cancer. World J Surg 2010, Nov;34(11):2539:44.
Khoshnoud MR, Löfdahl B, Fohlin H, Fornander T, Stål O, Skoog L, Bergh J, Nordenskjöld B.
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of
the long-term effect of adjuvant tamoxifen. Breast Cancer Res Treat., 2010 Oct 19. [Epub ahead of print]
Linderholm BK, Hellborg H, Johansson U, Skoog L, Lehtiö J. Vascular endothelial growth factor receptor 2 and
downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to
adjuvant endocrine treatment in steroid receptor positive breast cancer. Breast Cancer Res Treat. 2010 Nov
26. [Epub ahead of print]
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke
M, Davies C, Peto R, Bijker N, Solin L, Darby S. Overview of the randomized trials of radiotherapy in
ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162-77.
Sackey H, Sandelin K, Frisell J, Wickman M, Brandberg Y. Ductal carcinoma in situ of the breast. Long-term
follow-up of health-related quality of life, emotional reactions and body image. Eur J Surg Oncol. 2010,
Aug; 36 (8):756-62. Epub 2010 Jul 3.
Wilking U, Karlsson E, Skoog L, Hatschek T, Lidbrink E, Elmberger G, Johansson H, Lindström L, Bergh J.
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Br
Cancer Res Treat 2010; Jul 14.
37